Role of pyroptosis in atherosclerosis and its therapeutic implications

Citations Over TimeTop 10% of 2021 papers

Abstract

Atherosclerosis is a significant cardiovascular burden and a leading cause of death worldwide, recognized as a chronic sterile inflammatory disease. Pyroptosis is a novel proinflammatory regulated cell death, characterized by cell swelling, plasma membrane bubbling, and robust release of proinflammatory cytokines (such as interleukin IL-1β and IL-18). Mounting studies have addressed the crucial contribution of pyroptosis to atherosclerosis and clarified the candidate therapeutic agents targeting pyroptosis for atherosclerosis. Herein, we review the initial characterization of pyroptosis, the detailed mechanisms of pyroptosis, current evidence about pyroptosis and atherosclerosis, and potential therapeutic strategies that target pyroptosis in the development of atherosclerosis.

Related Papers

• → Role of pyroptosis in cardiovascular diseases(2018)284 cited
• → Mechanisms and Therapeutic Regulation of Pyroptosis in Inflammatory Diseases and Cancer(2020)190 cited
• → GSDME-Dependent Incomplete Pyroptosis Permits Selective IL-1α Release under Caspase-1 Inhibition(2020)91 cited
• → Pyroptosis, inflammasome, and gasdermins in tumor immunity(2023)35 cited
• → The research progression of virus infection and pyroptosis(2018)